国际皮肤性病学杂志    2004 30 (3): 152-154   ISSN: 2096-5540  CN: 32-1880/R   痤疮患者痤疮丙酸杆菌耐药性的研究进展 尹兴平, 夏隆庆 中国医学科学院、中国协和医科大学皮肤病研究所 南京 210042 收稿日期 2003-09-16  修回日期 null  网络版发布日期 null 参考文献  [1] Layton AM. Optimal management of acne to prevent scarring and psychological sequelae. Am J Clin Dermatol, 2001, 2:135-141. [2] Holland KT, Aldana O, Bojar RA, et al. Propionibacterium acnes and acne. Dermatology, 1998, 196:67-68. [3] Webster GF. Inflammatory acne represents hypersensitivity to Propionibacterium acnes. Dermatology, 1998, 196:80-81. [4] Webster GF, Leyden JJ, Norman ME, et al. Complement activation in acne vulgaris: in vitro studies with Propionibacterium acnes and Propionibacterium granulosum. Infect Immun, 1978, 22:523-529. [5] Nishijima S, Kurokawa I, Katoh N, et al. The bacteriology of acne vulgaris and antimicrobial susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne lesions. J Dermatol, 2000, 27:318-323. [6] Eady EA. Bacterial resistance in acne. Dermatology, 1998, 196:59. [7] Tan HH, Goh CL, Yeo MG, et al. Antibiotic sensitivity of Propionibacterium acnes isolates from patients with acne vulgaris in a tertiary dermatological referral centre in Singapore. Ann Acad Med Singapore, 2001, 30:22-25. [8] Ross JI, Snelling AM, Carnegie E,et al. Antibiotic-resistant acne:lessons from Europe. Br J Dermatol, 2003, 148:467-478. [9] Tan HH. Antibacterial therapy for acne: a guide to selection and use of systemic agents. Am J Clin Dermatol, 2003, 4:307-314. [10] Eady EA, Jones CE, Tipper JL, et al. Antibiotic resistant propionibacteria in acne: need for policies to modify antibiotic usage.BMJ, 1993, 306:555-556. [11] Espersen F. Resistance to antibiotics used in dermatological practice.Br J Dermatol, 1998, 139:4-8. [12] Westh H, Hougaard DM, Vuust J, et al. Prevalence of erm gene classes in erythromycin-resistant Staphylococcus aureus strains isolated between 1959 and 1988. Antimicrob Agents Chemother, 1995, 39(2):369-373. [13] Ross JI, Eady EA, Cove JH, et al. Resistance to erythromycin and clindamycin in cutaneous propionibaeteria is associated with mutations in 23S rRNA. Dermatology, 1998, 196:69-70. [14] Ross JI, Snelling AM, Eady EA, et al. Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the U. S.A., Japan and Australia. Br J Dermatol, 2001, 144:339-346. [15] Roberts MC. Tetracycline resistance determinants: mechanisms of action, regulation of expression, genetic mobility, and distribution.FEMS Microbiol Rev, 1996, 19:1-24. [16] Goulden V. Guidelines for the management of acne vulgaris in adolescents. Paediatr Drugs, 2003, 5:301-313. [17] Nam C, Kim S, Sim Y, et al. Anti-acne effects of Oriental herb extracts: a novel screening method to select anti-acne agents. Skin Pharmaeol Appl Skin Physiol, 2003, 16:84-90. [18] Ashkenazi H, Malik Z, Harth Y, et al. Eradication of Propionibacterium acnes by its endogenic porphyrins after illumination with high intensity blue light. FEMS Immunol Med Microbiol, 2003,35:17-24. 通讯作者: